NEJM Journal Watch
@jwatch
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
ID: 25952049
http://www.jwatch.org 23-03-2009 04:22:46
13,13K Tweet
60,60K Takipçi
123 Takip Edilen
In an interview with NEJM Group’s Dr. Jaye Hefner, Dr. Atul Malhotra, MD talks about the results of the phase 3 SURMOUNT-OSA studies that looked at tirzepatide for the treatment of obstructive sleep apnea and obesity. jwat.ch/3RGcuxA #ADA2024 #ADASciSessions